| Literature DB >> 31345748 |
Seyed-Omar Zaraei1, Mohammed I El-Gamal2, Zainab Shafique3, Sayyeda Tayyeba Amjad3, Saifullah Afridi4, Sumera Zaib3, Hanan S Anbar5, Randa El-Gamal6, Jamshed Iqbal7.
Abstract
In the current work, we report the discovery of new sulfonate and sulfamate derivatives of benzofuran- and benzothiophene as potent inhibitors of human carbonic anhydrases (hCAs) II, IX and XII. A set of derivatives, 1a-t, having different substituents on the fused benzofuran and benzothiophene rings (R = alkyl, cyclohexyl, aryl, NH2, NHMe, or NMe2) was designed and synthesized. Most of the derivatives exhibited higher potency than acetazolamide as inhibitors of the purified hCAII, IX and XII isoforms. The most potent inhibitors for hCAII, hCAIX and hCAXII were 1g, 1b and 1d with an IC50 ± SEM values of 0.14 ± 0.03, 0.13 ± 0.03 and 0.17 ± 0.06 µM, respectively. In addition, compounds 1d and 1n exerted preferential inhibitory effect against hCAXII isozyme with good potencies. Some selected compounds were docked within the active pocket of these isozymes and binding of the molecules revealed that sulfonate and sulfamate rings were located towards the active cavity and compounds coordinated to zinc ions.Entities:
Keywords: Benzofuran; Benzothiophene; Carbonic anhydrase; Isoform-selective inhibitors; Sulfamate; Sulfonate
Year: 2019 PMID: 31345748 DOI: 10.1016/j.bmc.2019.07.026
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641